Comment on Bar-Sela et al. Cannabis Consumption Used by Cancer Patients During Immunotherapy Correlates with Poor Clinical Outcome. <i>Cancers</i> 2020, <i>12</i>, 2447.

second-line between cannabis users and non-users resulted in: • Chi-square value (χ 2 ): 3.78 • p -value: 0.0518 • Degrees of freedom (dof): 1 • Expected frequencies: ○ First line: [26, 13] ○ Second line: [42, 21] The p -value of 0.0518 is very close to the 0.05 threshold, suggesting a borderline significance in the difference between cannabis users and non-users regarding whether immunotherapy was given as a first or second-line treatment.

also in 7,017 other papers